Cogent Biosciences, Inc. Quarterly Common Stock, Shares, Issued from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cogent Biosciences, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q3 2024.
  • Cogent Biosciences, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 110M shares, a 28.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 110M +24.3M +28.3% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 109M +24M +28.1% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 95.6M +24.7M +34.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 86.1M +16.2M +23.2% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 86.1M +16.3M +23.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 85.3M +19.6M +29.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 70.9M +25.1M +54.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 69.9M +26.1M +59.6% Dec 31, 2022 10-K 2024-02-26
Q3 2022 69.9M +30M +75.3% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 65.7M +25.9M +65% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 45.8M +8.62M +23.2% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 43.8M +11.5M +35.4% Dec 31, 2021 10-K 2023-03-14
Q3 2021 39.9M +29.2M +273% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 39.8M +8.67M +27.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 37.2M +6.37M +20.7% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 32.3M +24.7M +322% Dec 31, 2020 10-K 2022-03-15
Q3 2020 10.7M -20M -65.2% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 31.2M +501K +1.64% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 30.8M +703K +2.33% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 7.67M -22.4M -74.5% Dec 31, 2019 10-K 2021-03-16
Q3 2019 30.7M +738K +2.47% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 30.7M +793K +2.66% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 30.1M +19.9M +195% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 30.1M +19.9M +195% Dec 31, 2018 10-K 2020-03-26
Q3 2018 29.9M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 29.9M Jun 30, 2018 10-Q 2018-08-13
Q1 2018 10.2M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 10.2M Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.